In the present analysis, we retrospectively assessed hypoglycaemic episodes from a large dataset comprising sensor glucose and insulin delivery involving 60 adults with type 1 diabetes who participated in a randomized crossover study contrasting day‐and‐night hybrid closed‐loop insulin delivery and sensor‐augmented or conventional pump therapy. This evidence concerns the gene INS and type 1 diabetes mellitus.